Soleno Therapeutics, Inc. (SLNO)
USD 45.27
(-4.99%)
USD 45.27
(-4.99%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -24.94 Million | -20.78 Million | -27.77 Million | -25.22 Million | -17.37 Million | -11.68 Million |
| Net Income | -38.98 Million | -24.06 Million | -30.91 Million | -24.63 Million | -30.77 Million | -11.84 Million |
| Depreciation & Amortization | 1.95 Million | 1.96 Million | 1.96 Million | 1.95 Million | 1.95 Million | 1.96 Million |
| Deferred income taxes | -1.37 Million | - | -508 Thousand | -11.63 Million | 6.96 Million | -3.87 Million |
| Stock-based compensation | 5.94 Million | 2.53 Million | 3.27 Million | 1.5 Million | 825 Thousand | 988 Thousand |
| Change in working capital | 2.92 Million | -756 Thousand | -1.14 Million | 2.97 Million | 2.49 Million | 82 Thousand |
| Other non-cash items | 4.58 Million | -452 Thousand | -443 Thousand | 4.62 Million | 1.15 Million | 1 Million |
| Investing Cash Flow | - | -13 Thousand | -22 Thousand | -7000.00 | 528 Thousand | -180 Thousand |
| Investments in PPE | - | -13 Thousand | -22 Thousand | -7000.00 | -21 Thousand | -8000.00 |
| Acquisitions | - | - | - | - | 500 Thousand | - |
| Investment purchases | - | - | - | - | -500 Thousand | - |
| Sales/Maturities of investments | - | - | - | - | 500 Thousand | - |
| Other Investing Activities | - | - | - | - | 49 Thousand | -172 Thousand |
| Financing Cash Flow | 180.01 Million | 14.09 Million | -128 Thousand | 53.72 Million | 14.48 Million | 17.82 Million |
| Debt repayment | - | - | -8000.00 | -17 Thousand | -2000.00 | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -16.00 | -120.00 | - | - | - |
| Common Stock Issuance | 180.01 Million | 15.15 Million | - | 53.72 Million | 14.48 Million | 16.5 Million |
| Other Financing Activities | 42.16 Million | -1.05 Million | -119.88 Thousand | 17 Thousand | 14.48 Thousand | 1.32 Million |
| Accounts receivables | - | - | - | - | 64 Thousand | -64 Thousand |
| Accounts payables | 1.37 Million | -1.47 Million | -235 Thousand | 1.49 Million | 1.06 Million | 249 Thousand |
| Inventory | - | - | - | - | -64 Thousand | - |
| Other working capital | 1.55 Million | 721 Thousand | -913 Thousand | 1.48 Million | 1.43 Million | -167 Thousand |
| Cash at beginning of period | 14.6 Million | 21.3 Million | 49.22 Million | 20.73 Million | 23.09 Million | 17.13 Million |
| Cash at end of period | 169.68 Million | 14.6 Million | 21.3 Million | 49.22 Million | 20.73 Million | 23.09 Million |
| Capital Expenditure | - | -13 Thousand | -22 Thousand | -7000.00 | -21 Thousand | -8000.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 155.07 Million | -6.7 Million | -27.92 Million | 28.49 Million | -2.36 Million | 5.96 Million |
| Free Cash Flow | -24.94 Million | -20.79 Million | -27.79 Million | -25.23 Million | -17.39 Million | -11.69 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -21.85 Million | -21.39 Million | -38.98 Million | -11.29 Million | -10.86 Million | -8.47 Million |
| Depreciation & Amortization | 494 Thousand | 490 Thousand | 1.95 Million | 489 Thousand | 490 Thousand | 489 Thousand |
| Deferred income taxes | - | - | -1.37 Million | -2.85 Million | 653 Thousand | -1000.00 |
| Stock-based compensation | 7.16 Million | 6.44 Million | 5.94 Million | 1.9 Million | 2.2 Million | 1.2 Million |
| Change in working capital | -4.04 Million | 1.93 Million | 2.92 Million | 1.9 Million | 98 Thousand | 811 Thousand |
| Other non-cash items | 13.03 Million | 2.55 Million | 4.58 Million | 3.53 Million | 1.08 Million | 406 Thousand |
| Investing Cash Flow | -120.92 Million | -115.24 Million | - | - | - | - |
| Investments in PPE | -8000.00 | -11 Thousand | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -145.91 Million | -115.23 Million | - | - | - | - |
| Sales/Maturities of investments | 25 Million | - | - | - | - | - |
| Other Investing Activities | -120.91 Million | -115.23 Million | - | - | - | - |
| Financing Cash Flow | 152.74 Million | 938 Thousand | 180.01 Million | 123.55 Million | 39.4 Million | 17.06 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 152.74 Million | 938 Thousand | 180.01 Million | 123.55 Million | 2.87 Million | 17.06 Million |
| Other Financing Activities | 152.74 Million | 938 Thousand | 42.16 Million | 123.55 Thousand | 36.52 Million | 17.06 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -4.29 Million | 4.86 Million | 1.37 Million | 34 Thousand | -341 Thousand | 678 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 254 Thousand | -2.92 Million | 1.55 Million | 1.87 Million | 439 Thousand | 133 Thousand |
| Cash at beginning of period | 42.84 Million | 169.68 Million | 14.6 Million | 52.43 Million | 19.36 Million | 7.87 Million |
| Cash at end of period | 57.02 Million | 42.84 Million | 169.68 Million | 169.68 Million | 52.43 Million | 19.36 Million |
| Capital Expenditure | -8000.00 | -11 Thousand | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 14.17 Million | -126.83 Million | 155.07 Million | 117.24 Million | 33.06 Million | 11.49 Million |
| Free Cash Flow | -17.65 Million | -12.53 Million | -24.94 Million | -6.31 Million | -6.33 Million | -5.56 Million |
4488
SAFT
300127
3760
TSLA
002450